Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |